Pharmacoeconomics
From Wikipedia, the free encyclopedia
Pharmacoeconomics refers to the scientific discipline that compares the value of one pharmaceutical drug or drug therapy to another. It is a sub-discipline of Health economics. A pharmacoeconomic study evaluates the cost (expressed in monetary terms) and effects (expressed in terms of monetary value, efficacy or enhanced quality of life) of a pharmaceutical product. We can distinguish several types of pharmacoeconomic evaluation:cost-minimization analysis, cost-benefit analysis, cost-effectiveness analysis and cost-utility analysis. Pharmacoeconomic studies serve to guide optimal healthcare resource allocation, in a standardized and scientifically grounded manner.
One important consideration in a pharmacoeconomic evaluation is to decide the perspective from which the analysis should be conducted (such as institutional or societal).
A complete compilation of cost-utility analyses in the peer reviewed medical literature is available at the The CEA Registry Website.
[edit] Academic resources
- PharmacoEconomics, ISSN 1170-7690, Adis International
- Value in Health, ISSN: 1524-4733 (internet), 1098-3015 (print), Blackwell Publishing
[edit] See also
- Cost-minimization analysis
- Cost-effectiveness analysis
- Cost-benefit analysis
- Cost-of-illness
- Cost-utility analysis
- Disability-adjusted life years - DALYs
- Global burden of disease
- Global comparative cost of pharmaceutical molecule
- Health utility index
- Health-adjusted life years - HALYs
- Perspective (pharmacoeconomic)
- Quality-adjusted life years - QALYs
- Quality of life
[edit] External links
- International Society For Pharmacoeconomics and Outcomes Research
- ISPOR-CO, The Colombian Chapter of The International Society for Pharmacoeconomics and Outcomes Research
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
